Trial intelligence / Profile preview

Gabapentin in POTS Pilot Study

NCT04345432Completed

Sponsor
MedStar Health Research Institute
Start
Jan 2014
Primary completion
Sep 2017
Modality
Small Molecules
01

Overview

Randomised, double-blind trial in postural orthostatic tachycardia syndrome (POTS) comparing Gabapentin First with Placebo First (2 arms). Primary endpoint: Acute Panic Inventory at 3 weeks. Started Jan 2014; status: completed.

02

Drugs

gabapentin
03

Conditions

postural orthostatic tachycardia syndrome (POTS)

Beyond the preview

Go deeper on NCT04345432.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04345432.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call